Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura

IF 3.2 4区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Current Research in Translational Medicine Pub Date : 2024-03-01 DOI:10.1016/j.retram.2024.103441

Lorenzo Lazzari , Lucia Bongiovanni , Paola Ronchi , Gregorio Maria Bergonzi , Camilla Gariazzo , Elisa Diral , Fabio Ciceri , Andrea D'Alessio , Maurilio Ponzoni

引用次数: 0

查看原文本刊更多论文

新一代测序技术在获得性巨核细胞性血小板减少性紫癜中的作用

无摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Research in Translational Medicine Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology

CiteScore

7.00

自引率

4.90%

发文量

审稿时长

45 days

期刊介绍： Current Research in Translational Medicine is a peer-reviewed journal, publishing worldwide clinical and basic research in the field of hematology, immunology, infectiology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases (2017 Impact Factor is 1.9). Core areas covered in Current Research in Translational Medicine are: Hematology, Immunology, Infectiology, Hematopoietic, Cell Transplantation, Cellular and Gene Therapy.